Symposium:
170. Diagnostic Updates: Clinical Mycology Update
Friday, October 5, 2018: 3:30 PM-4:45 PM
Room: N 24

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • explain the principles, advantages, and limitations of MALDI-TOF MS as a diagnostic tool for the identification of clinical fungal pathogens
  • discuss methodologies, indications, interpretation, and predictive value of in vitro antifungal resistance testing
  • understand laboratory diagnosis of emerging fungal pathogens

Target Audience: Academicians, Clinicians, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists

Tracks: Trainee, Pediatric ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID


Moderators:  Randall Hayden, MD, St. Jude Children's Research Hospital and Karen C. Carroll, MD, FIDSA, Johns Hopkins University School of Medicine

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-245-L01-P

Disclosures:

R. Hayden, Roche Molecular: Scientific Advisor , Consulting fee . Abbott Molecular: Scientific Advisor , Consulting fee . Quidel: Scientific Advisor , Consulting fee .

K. C. Carroll, Singulex, Inc.: Consultant , Consulting fee . GenMark, Inc.: Research Contractor , Research funds paid to my institution and Research support .

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.